Richard Landin

Title: Richard Landin: Innovator in Cancer Treatment

Introduction

Richard Landin is a notable inventor based in San Diego, CA. He has made significant contributions to the field of cancer treatment through his innovative methods. His work focuses on addressing genetic alterations that contribute to cancer progression.

Latest Patents

Richard Landin holds a patent for "Methods for the treatment of cancer." This patent discloses methods of treating cancer in a subject known to possess at least one genetic alteration in RET. The treatment involves administering a therapeutically effective amount of a specific compound, N-[3-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl]-N'-[5-(2,2,2-trifluoro-1,1-dimethylethyl)-3-isoxazolyl]-urea, or a pharmaceutically acceptable salt thereof. He has 1 patent to his name.

Career Highlights

Richard Landin is currently associated with Ignyta, Inc., where he continues to work on innovative solutions for cancer treatment. His expertise and dedication to research have positioned him as a valuable asset in the field.

Collaborations

Some of his notable coworkers include Jonathan Ee-ren Lim and Pratik S Multani. Their collaborative efforts contribute to advancing cancer treatment methodologies.

Conclusion

Richard Landin's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His contributions are paving the way for new therapeutic approaches that could benefit many patients.